Biologics Market, Global, Segment, Region, Country, Size, Growth, Forecasts, Trends

LONDON, GREATER LONDON, UK, March 20, 2019 /EINPresswire.com/ -- The growth rate in the global biologics market has accelerated recently and is now almost 10% year on year. By 2022 the biologics market which is part of the pharmaceutical market will be worth $350 billion. 52% of the top 100 pharma products’ sales value will then come from biologics, as established chemical pharmaceuticals drop off the patent cliff and new breakthrough biologics are approved. All three of the market’s major segments, monoclonal antibodies, therapeutic proteins and the vaccines market, are growing at close to the overall market rate.

Metabolic disorders are the largest therapeutic treatment area for the global biologics market, followed by cancer, cardiovascular diseases and immunological diseases. North America is the largest regional market for these drugs and also the fastest-growing, though Asia Pacific is growing almost as fast.

Request A Free Sample Copy Of Biologics Market @ https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smp

Biologics Market, Global Opportunities And Strategies To 2021 is one of a series of new reports from The Business Research Company that provides biologics market overviews, analyze and forecast biologics market size and growth for the whole market, biologics industry segments and geographies, trends, drivers, restraints, leading competitors’ revenues, profiles and market shares in over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read the Biologics Market, Global Opportunities And Strategies To 2021 from The Business Research Company for information on the following:
Markets Covered: Global biologics market, monoclonal antibodies market, therapeutic proteins market and vaccines market.
Biologics Companies Mentioned: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squib, Pfizer, Eli Lilly and Company, F. Hoffmann-La Roche, Merck & Co., GlaxoSmithKline, Sanofi
Countries: USA, Japan, Germany, France, Australia, Brazil, Italy, China, Russia, Spain, UK, India.
Regions: North America, Western Europe, Asia Pacific, Eastern Europe, Middle East, South America, Africa.
Time Series: Five years historic (2013-2017) and forecast (2017-2021).
Data: Ratios of market size and growth to related markets, population, GDP, Biologics Indicators Comparison.
Strategies For Participants In The Biologics Market: The report explains 23 trend-based strategies for biologics, pharma and healthcare, including investing in oral delivery of therapeutic proteins, investing in slow drug release function and Roche’s strategy of reducing its small molecule capacity and expanding its biologics capacity.
Opportunities For Biologics And Pharma Companies: The report reveals the global, regional and country subsegments where the biologics, pharma and healthcare market will put on most $ sales up to 2021.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments historic and forecast data (monoclonal antibodies, therapeutic proteins and vaccines market), biologics market comparison with industry metrics.
Other Information: Biologics market trends and strategies, drivers and restraints, PESTLE analysis, global biologics market compared with similar markets, 2017, top company profiles, biologics market key mergers and acquisitions.
Number of Pages: 218
Number of Figures: 84
Number of Tables: 82
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Interested to know more? Here is a list of reports similar to “Biologics Market, Global Opportunities And Strategies To 2021”(https://www.thebusinessresearchcompany.com/report/biologics-global-market-opportunities-and-strategies-to-2021):
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021(https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-opportunities-and-strategies-to-2021)
Contract Research Organizations Global Market Opportunities And Strategies To 2021(https://www.thebusinessresearchcompany.com/report/contract-research-organizations-global-market-opportunities-and-strategies-to-2021)

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn